microRNA与急性移植物抗宿主病研究进展
Advances in microRNA and graft-versus-host disease
摘要
急性移植物抗宿主病(aGVHD)是异基因造血干细胞移植(allo-HSCT)后的常见并发症之一,重度aGVHD患者病死率高。HLA全相合患者allo-HSCT aGVHD发生率为40%~60%,HLA不全相合患者发生率更高[1]。aGVHD发病机制复杂,通常认为与免疫激活、炎症因子释放、细胞数量的改变和影响GVHD中的特定蛋白质水平有关。目前临床上诊断aGVHD主要根据临床特征及病理学证据,仍然缺乏监测、诊断aGVHD的生物标志物。最近,许多文献报道microRNA (miRNA)在aGVHD及肿瘤方面有重要作用。本文我们将miRNA在aGVHD中的研究进展进行综述。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2015年第10期894-896,共3页
Chinese Journal of Hematology
参考文献29
-
1Cahn JY, Klein JP, Lee SJ, et al. Prospective evaluation of 2acute graft- versus- host (GVHD) grading systems: a jointSoci^te Frai^aise de Greffe de Moelle et Th6rapie Cellulaire(SFGM- TC), Dana Farber Cancer Institute (DFCI), andInternational Bone Marrow Transplant Registry (IBMTR)prospective study [J]. Blood, 2005,106(4):1495-1500.
-
2Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, andfunction[J]. Cell, 2004,116(2):281-297.
-
3Alexiou P, Maragkakis M,Papadopoulos GL, et al. The DIANA-mirExTra web server: from gene expression data to microRNAfunction[J]. PLoS One, 2010, 5(2):e9171.
-
4Betel D, Wilson M, Gabow A,et al. The microRNA.orgresource: targets and expression[j]. Nucleic Acids Res, 2008, 36(Database issue): D149-D153.
-
5Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, oftenflanked by adenosines, indicates that thousands of human genesare microRNA targets[ J]. Cell, 2005, 120(1):15-20.
-
6Sales G, Coppe A, Bisognin A, et al. MAGIA, a web-based toolfor miRNA and Genes Integrated Analysis [J]. Nucleic AcidsRes, 2010,38(Web Server issue):W352-W359.
-
7Atarod S, Dickinson AM. MicroRNAs: The Missing Link in theBiology of Graft- Versus- Host Disease. [J]. Front Immunol,2013,4:420.
-
8Allantazl F, Cheng DT, Bergauer T,et al. Expression profiling of humanimmune cell subsets identifies miRNA- mRNA regulatoryrelationships correlated with cell type specific expression [J].PLoS One, 2012,7(1):e29979.
-
9Lee RC, Ambros V. An extensive class of small RNAs inCaenorhabditis elegans[j]. Science, 2001,294(5543):862-864.
-
10Lagos-Quintana M, Rauhut R,Yalcin A, et al. Identification oftissue-specific microRNAs from mouse [J]. Curr Biol, 2002, 12(9):735-739.
二级参考文献12
-
1Iorio MV, Ferracin M, Liu CG, et al. microRNAs gene expression deregulation in human breast cancer. Cancer Res, 2005 ; 65 (16) : 7065-7070.
-
2Wang Y, Lee AT, Ma JZ, et al. Profiling microRNAs expression in hepatocellular carcinoma reveals microRNAs-224 up-regulation and apoptosis inhibitor-5 as a microRNAs-224- specific target. J Biol Chem,2008;283(19):13205-13215.
-
3Chan JA, Krichevsky AM, Kosik KS. microRNAs 21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res, 2005 ; 65(14) : 6029-6033.
-
4Yanaihara N, Caplen N, Bowman E, et al. Unique microRNAs molecular profiles in lung cancer diagnosis and prognosis. Cancer Ce11,2006;9(3) : 189-198.
-
5Fulci V, Chiaretti S, Goldoni M, et al. Quantitative technologies establish a novel microRNAs profile of chronic lymphocytic leukemia. Blood,2007; 109(17) :4944-4951.
-
6Wichramasinghe NS, Manavalan TT, Dougherty SM, et al. Estradiol downregulates miR-21 expression and increases miR- 21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res, 2009 ; 37 (8) : 2584-2595.
-
7Crawford M, Brawner E, Batte L, et al. microRNAs-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Bioph Res Co,2008;373(4):607-612.
-
8Hanke M, Hoefig K,Merz H, et al. A robust methodology to study urine microRNAs as tumor marker: microRNAs-126 and mieroRNAs-182 are related to urinary bladder cancer. Urol Oncol,2009 ;28(6) :655-661.
-
9Wang CJ, Zhou ZG, Wang L, et al. Clinicopathological significance of microRNAs-31,-143 and -145 expression in colorectal cancer. Dis Markers, 2009 ; 26 (1): 27-34.
-
10Akao Y, Nakagawa Y, Lio A, et al. Role of microRNAs-143 in Fas-mediated apoptosis in human T-cell leukemia Jurkat cells. Leukemia Res,2009;33(11) :1530-1538.
共引文献17
-
1郑文静,胡晓霞.miR-21与宫颈癌关系的研究进展[J].广西医学,2014,36(4):484-487. 被引量:2
-
2吴夕,缪珩.microRNA-21对人甲状腺乳头状癌细胞增殖和凋亡的影响[J].南京医科大学学报(自然科学版),2014,34(4):437-441. 被引量:3
-
3王晓山,张占学,林林,李涛,邱少凡,张海强,宋伟庆.miR-126在人结肠癌细胞中的表达及其对结肠癌细胞耐药性的影响[J].现代消化及介入诊疗,2014,19(4):226-229. 被引量:3
-
4孟炜,赵辉,台艳,张琪,易述红,许赤,李华,杨扬,陈规划.微小RNA在肝细胞癌中的研究进展[J].中华肝脏外科手术学电子杂志,2015,4(3):191-192.
-
5张潍,黄大业,张晋,王辉.microRNA-143在非小细胞肺癌中的表达及临床病理意义[J].现代肿瘤医学,2015,23(20):2933-2936.
-
6李金媚,吴爱兵,杨志雄.miR-373与肿瘤侵袭转移研究进展[J].中华实用诊断与治疗杂志,2015,29(10):946-948. 被引量:7
-
7安蓬蓬,汤华,郭军飞.血浆miRNA-372/373在正常献血者和HBV早期感染献血者中的表达差异[J].天津医科大学学报,2015,21(6):503-506. 被引量:1
-
8郭兰娇,兰芳,王孟丽.苦参碱联合顺铂对宫颈癌SiHa细胞株内分泌功能以及恶性生物学行为的影响[J].海南医学院学报,2016,22(1):13-15. 被引量:9
-
9闫杨,孙学国,陈力,孙莉娟,路艳艳,姜志荣,李玲,刘希双.甲醛对肝脏miRNA-21及其下游TIMP-3和RECK蛋白的影响[J].世界华人消化杂志,2016,24(14):2143-2151. 被引量:2
-
10胡文格,陈彩霞,柯学礼.组织微小RNA-21表达和高危型人类乳头瘤病毒载量与宫颈癌发生发展的相关性[J].中国肿瘤临床与康复,2016,23(7):776-779. 被引量:1
-
1董秀娟,陈蕾,韩利杰,马红霞,朱趁红,赵晓武.异基因造血干细胞移植治疗67例移植物抗宿主病分析[J].医药论坛杂志,2011,32(3):16-18. 被引量:2
-
2张兴平,陈庆伟.慢性心力衰竭大鼠心肌细胞合成细胞因子增强[J].基础医学与临床,2007,27(6):700-701. 被引量:1
-
3章卫平,王健民,童书鹏,闵碧荷,李红梅,钱宝华,肖作平,沈茜,潘竹林,周虹.HLA不全相合外周血造血干细胞移植治疗三例急性淋巴细胞白血病[J].中华血液学杂志,2000,21(8):421-422. 被引量:1
-
4冯茹,刘代红,许兰平,陈欢,张晓辉,韩伟,赵婷,刘开彦,黄晓军.不同供者来源的造血干细胞移植后急性移植物抗宿主病的临床特征研究[J].中华血液学杂志,2010,31(11):732-735. 被引量:11
-
5李夏新,黄志光,周芷芬,何杏,李春富,刘卫宁,张肇和.小儿HLA不全相合骨髓移植7例报告[J].第一军医大学学报,1994,14(3):232-233.
-
6李夏新,黄志光,罗深秋,张肇和,程少杰,周芷芬,钱新华,陈永清,崔玉明.HLA不全相合骨髓移植后急性GVHD的特点及皮肤超微结构改变[J].中华血液学杂志,1995,16(4):209-210.
-
7刘会兰,孙自敏,耿良权,汤宝林,童娟,袁晓,姚文,吴振添,王祖贻.亲缘HLA不全相合造血干细胞移植治疗血液病11例[J].中国实用内科杂志,2007,27(S1):132-133. 被引量:1
-
8郭广兰,刘湘林,范毅,王俊娟.1例HLA不全相合非血缘异基因脐血干细胞移植的护理[J].西南国防医药,2003,13(1):82-83.
-
9文钦,陈幸华,高蕾,张曦,张诚,高力,曾韫璟,孔佩艳,刘红,彭贤贵.人脐带间充质干细胞治疗移植物抗宿主病的临床观察[J].中国输血杂志,2012,25(2):123-126. 被引量:4
-
10张献怀.解放军总医院第一附属医院:治疗恶性黑色素瘤技高一筹[J].老年健康,2007(9):6-6.